Atlas Trials

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

Clinical trial NCT05867004 · RECRUITING

Trial details

NCT number
NCT05867004
Sponsor
Institut Claudius Regaud
Status
RECRUITING
Study type
OBSERVATIONAL
MelanomaImmune DefectTumor Skin
Start date
2023-01-01
Primary completion
2025-07-03
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.